WENDY RIDENOUR: Open Payments
NPI 1114178282 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,087 in 91 payments from 19 companies in 2025. Trend: 2023 $1,875 · 2024 $1,867 · 2025 $2,087
Food & beverage: $1,988Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $350 |
| Janssen Biotech, Inc. | 10 | $303 |
| Arcutis Biotherapeutics, Inc. | 7 | $197 |
| Novartis Pharmaceuticals Corporation | 10 | $176 |
| Incyte Corporation | 4 | $176 |
| UCB, Inc. | 7 | $138 |
| ABBVIE INC. | 17 | $135 |
| Lilly USA, LLC | 4 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Amgen Inc. | 4 | $80 |
Products named: DUPIXENT, TREMFYA, Zoryve, OPZELURA, Bimzelx, COSENTYX, SKYRIZI, EBGLYSS.
Industry payments across AZ — which companies pay providers there.
